Ask AI

Transforming Lymphoma Management: Practical Integration of CAR T‑Cell Therapies for Improved Outcomes

Enhance your knowledge of CAR T-cell therapies currently used to manage relapsed or refractory B-cell non-Hodgkin lymphoma to select appropriate candidates and formulate evidence-based strategies to improve patient outcomes through an expert-written ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides. 

Share

Program Content

Events

  • Live Event
    Transforming Lymphoma Management: Practical Integration of CAR T Cell Therapies for Improved Outcomes
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Expert Office Hours CAR T Lymphoma
ClinicalThought Expert Office Hours Forum: Transforming Lymphoma With CAR T-cell Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb